Kemira, FI0009004824

Kemira completes SIDRA deal. Kemira stock gains 2.32 percent

Published on 10/02/2026 at 16:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 revenue reached EUR 693.0 million, with a 16.1 percent operative margin. Kemira stock costs EUR 17.23 on October 2, 2026 after EUR 16.84.

Isometrische 3D-Illustration einer Zellstoff-Prozesskette mit Tanks
Kemira Oyj FI0009004824 unterstützt die Wertschöpfungskette von Zellstoff und Wasseraufbereitung mit Prozesschemikalien, Illustration mit AI erstellt.

Kemira (ISIN FI0009004824) completed its acquisition of SIDRA Wasserchemie on October 1, 2026, while Kemira stock was trading at EUR 17.23 at Lang & Schwarz on October 2, 2026 at 4:30 p.m. CEST, up 2.32 percent versus the EUR 16.84 prior close on October 1. As Cision reported on October 1, the deal strengthens Kemira's Water Solutions business in Western and Central Europe. The market reaction puts the acquisition alongside a still pressured profitability picture.

SIDRA expands water treatment

SIDRA produces coagulants at two facilities in Germany and serves municipal and industrial water-treatment customers in Germany, Belgium and the Netherlands. The transaction gives Kemira an additional regional platform in its core Water Solutions business, making the acquisition strategically relevant beyond its immediate revenue contribution.

The deal follows Kemira's wider push toward water and renewable solutions. Its investor materials describe water as the key contributor to future revenue growth, while the company continues to operate across Water Solutions, Packaging and Hygiene Solutions and Fiber Essentials.

Q2 margin shows cost pressure

According to Kemira in its Half-Year Financial Report published on July 17, 2026, Q2 2026 revenue was EUR 693.0 million and operative EBITDA, or earnings before interest, taxes, depreciation and amortization, was EUR 111.7 million. The operative EBITDA margin was 16.1 percent, showing that cost inflation and lower prices continued to weigh on earnings quality.

Kemira's 2026 outlook calls for revenue of EUR 2.6 billion to EUR 3.0 billion and operative EBITDA of EUR 400 million to EUR 500 million. That range gives investors a clear benchmark for the January to September report, which the company has scheduled for October 23, 2026.

Stock rises below yearly high

The Lang & Schwarz quote of EUR 17.23 stands EUR 4.23 below the 52-week high of EUR 21.46 and EUR 1.94 above the 52-week low of EUR 15.29, both as of October 2, 2026. The EUR 2.5 billion market capitalization places the acquisition in the context of a mid-cap Finnish chemicals company rather than a transformational transaction on its own.

Kemira's investor page also lists a EUR 0.38 second dividend installment with a record and payment date of October 5, 2026. For investors, the key test is whether water-treatment expansion can offset the margin pressure visible in Q2 2026 while the company works within its full-year outlook.

October report sets next test

Kemira shares are listed on Nasdaq Helsinki under the ticker KEMIRA. The next interim report on October 23, 2026 should provide the first reported evidence of demand, pricing and cost trends after the SIDRA transaction.

The further course of trading is shown by the continuously updated real-time quote of Kemira stock.

Kemira stock at a glance

  • Company: Kemira Oyj
  • ISIN: FI0009004824
  • Ticker: KEMIRA
  • Primary exchange: Nasdaq Helsinki
  • Price Lang & Schwarz (as of October 2, 2026, 4:30 p.m. CEST): EUR 17.23
  • Change versus prior close: plus 2.32 percent
  • Prior close Lang & Schwarz (October 1, 2026): EUR 16.84
  • Market capitalization: EUR 2.5 billion (as of October 2, 2026)
  • 52-week range: EUR 15.29-21.46 (as of October 2, 2026)
  • Sector / Industry: Basic Materials / Chemicals
  • Next earnings date: October 23, 2026

More news and analyses on Kemira stock

Disclaimer...

en | FI0009004824 | KEMIRA | boerse | 70216285 | bgmi